Belgian Central Sleep Apnea REgistry
ConditionCentral Sleep Apnea
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven
This study evaluates different factors that determine the treatment choice and treatment compliance in patients with central sleep apnea. All patients will receive routine care (registry).
Age ≥ 18 years old
An apnea/hypopnea index ≥ 15/h of sleep and proportion of non-obstructive events > 50%, derived from polysomnography (diagnostic or during (PAP) treatment)
Written informed consent provided
None
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
Philips Respironics
Collaborator